Reprogramming Tumor-Associated Macrophages To Reverse EGFR<sup>T790M</sup> Resistance by Dual-Targeting Codelivery of Gefitinib/Vorinostat
Huige PengShanghai
Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, ChinaBinfan ChenShanghai
Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, ChinaWei HuangShanghai
Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, ChinaYubo TangShanghai
Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, ChinaYifan JiangShanghai
Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, ChinaWenyuan ZhangShanghai
Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, ChinaYongzhuo HuangShanghai
Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China
2017en
ABI
Abstract
-caused resistance to tyrosine kinase inhibitor treatment.
Identifiers
Citations and references
Cited by 30 references